| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/20/1997 | CN1157566A Phosphonates and parathyroid hormone for osteoporosis |
| 08/20/1997 | CN1157565A Method for treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
| 08/20/1997 | CN1157287A Arylalkyl diazinones |
| 08/20/1997 | CN1157151A Memory oral liquor and producing method thereof |
| 08/20/1997 | CN1157142A Longshe Fukangling powder and its preparing method |
| 08/20/1997 | CN1157136A Pharmaceutical agents for treatment of acute and chronic inflammatory diseases |
| 08/19/1997 | US5659048 Chiral [[(2-bromoethyl)-amino]methyl]-2-nitro-1H-imidazol-1-ethanol and related compounds |
| 08/19/1997 | US5659033 Psychological disorders |
| 08/19/1997 | US5659018 Mocarhagin, a cobra venom protease, and therapeutic uses thereof |
| 08/19/1997 | US5658956 Bioadhesive-wound healing compositions and methods for preparing and using same |
| 08/19/1997 | US5658949 Inhibition of tumor necrosis factor by retinoic acid |
| 08/19/1997 | US5658945 Anticancer agent; aids therapy; controlling infections |
| 08/19/1997 | US5658944 Anticholesterol agents |
| 08/19/1997 | US5658940 Inhibitors of tumor necrosis factor |
| 08/19/1997 | US5658933 Enzyme inhibitors of proline and lysine hydroxylases necessary for the biosynthesis of collagen; antifibrotic agents; respiratory, liver and skin disorders; atherosclerosis; antiscarring agents |
| 08/19/1997 | US5658932 Azacyclic compounds; cognitive function stimulants; alzheimer's disease |
| 08/19/1997 | US5658929 Anticoagulants |
| 08/19/1997 | US5658925 Aminobenzoic acid derivatives |
| 08/19/1997 | US5658922 4-aza-pregnane 5α-reductase isozyme 1 inhibitors |
| 08/19/1997 | US5658910 Nicotinic acid esters |
| 08/19/1997 | US5658906 Cysteine protease and serine protease inhibitors |
| 08/19/1997 | US5658903 Cytokine inhibitors |
| 08/19/1997 | US5658902 Quinazolines as inhibitors of endothelin converting enzyme |
| 08/19/1997 | US5658888 Enterokinesis stimulating action |
| 08/19/1997 | US5658885 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
| 08/19/1997 | US5658883 Biologically active TGF-β1 peptides |
| 08/19/1997 | US5658882 Methods of inducting formation of tendon and/or ligament tissue comprising administering BMP-12, BMP-13, and/or MP-52 |
| 08/19/1997 | US5658776 Generation of high titers of recombinant AAV vectors |
| 08/19/1997 | US5658774 Inhibiting growth of tumor cells expressing oncogenes by introducing in vitro dna sequence encoding interferon regulatory factor, expressing said sequence |
| 08/19/1997 | US5658581 Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition and composition obtained |
| 08/19/1997 | US5658568 Cytotoxic drug therapy |
| 08/19/1997 | CA2007651C Anti-inflammatory 1-heteroaryloxindole-3-carboxamides |
| 08/19/1997 | CA1339305C Production of human somatomedin c |
| 08/17/1997 | CA2197611A1 Pseudopeptides derives from neurokinins and their preparation process |
| 08/14/1997 | WO1997029109A1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/14/1997 | WO1997029092A1 Histamine h3 receptor ligands |
| 08/14/1997 | WO1997028822A1 Composition and method for causing photodynamic damage to target cells |
| 08/14/1997 | CA2244745A1 Histamine h3 receptor ligands |
| 08/13/1997 | EP0788792A1 Matrix type patch preparation |
| 08/13/1997 | EP0788789A1 Ranitidine compositions and their use for the treatment of minor gastrointestinal disorders associated with excess acid secretion |
| 08/13/1997 | EP0788509A1 Therapeutic peptide derivatives |
| 08/13/1997 | EP0788503A1 Novel quinoxalindione derivatives, their production and use in medicaments |
| 08/13/1997 | EP0788497A1 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis |
| 08/13/1997 | EP0788491A1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives |
| 08/13/1997 | EP0788490A1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 08/13/1997 | EP0788478A1 Azetidinone derivatives for the treatment of atherosclerosis |
| 08/13/1997 | EP0788476A1 Stilbene derivatives useful as cyclooxygenase-2 inhibitors |
| 08/13/1997 | EP0788388A1 Device for aerosolized delivery of peptide drugs |
| 08/13/1997 | EP0788383A2 Modulation of cell proliferation and wound healing |
| 08/13/1997 | EP0788367A1 Stretch-activated cation channel and antisense oligonucleotides thereto |
| 08/13/1997 | EP0788362A1 Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism |
| 08/13/1997 | EP0788361A1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 08/13/1997 | EP0788360A1 Boronic ester and acid compounds, synthesis and uses |
| 08/13/1997 | EP0788359A1 Compositions useful for the preparation of medicines for treating a variety of intractable disorders |
| 08/13/1997 | EP0788358A2 Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases |
| 08/13/1997 | EP0788352A1 Treatment of animals |
| 08/13/1997 | EP0788308A1 Polymeric wound healing accelerators |
| 08/13/1997 | EP0788307A1 Oligonucleotide modulation of multidrug resistance-associated protein |
| 08/13/1997 | EP0658099B1 Anti-free-radical topical composition based on a superoxide dismutase and a phosphonic derivative |
| 08/13/1997 | EP0607124B1 Alteration of rate and character of hair growth |
| 08/13/1997 | EP0486666B1 Therapeutic heterocyclic compounds |
| 08/13/1997 | CN1156995A Vitronectin receptor antagonists |
| 08/13/1997 | CN1156993A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/13/1997 | CN1156989A N-Substituted azabicycloheptane derivatives and preparing process and use thereof |
| 08/13/1997 | CN1156965A Cytokine regulatory agents and method of use in pathologies and conditions associated with altered cytokine levels |
| 08/13/1997 | CN1156964A Novel Peptides |
| 08/13/1997 | CN1156961A Formulations and method for providing prolonged local anesthesia |
| 08/13/1997 | CN1156611A Health medicinal liquor for discotinuing habit of smoking and detoxifying, and producing process thereof |
| 08/13/1997 | CN1156594A Health beautifying wine |
| 08/13/1997 | CN1156593A 坡马保健酒 Poe Mabao Jian wine |
| 08/13/1997 | CN1035616C 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 08/12/1997 | US5656725 Stabilize inappropriate cell proliferation or cell death |
| 08/12/1997 | US5656672 Water-in-oil emulsion containing retinol its use |
| 08/12/1997 | US5656660 Amine or guanidine group-containing tryptase inhibitor |
| 08/12/1997 | US5656656 Drug for treating osteoporosis bone disorder |
| 08/12/1997 | US5656654 Tyrosine kinase inhibitors |
| 08/12/1997 | US5656652 Compositions containing histamine-H2 -receptor antagonists at low dosage |
| 08/12/1997 | US5656647 Administering; useful in x-ray therapy, exposure to nuclear radition and anticarcinogenic agents |
| 08/12/1997 | US5656639 Heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present |
| 08/12/1997 | US5656633 Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent, central nervous system stimulant or sigma receptor agonist |
| 08/12/1997 | US5656627 Inhibitors of interleukin-1β converting enzyme |
| 08/12/1997 | US5656623 Bactericides; antibiotics |
| 08/12/1997 | US5656612 Antisense oligonucleotide modulation of raf gene expression |
| 08/12/1997 | US5656598 Use of fibroblast growth factors to stimulate bone growth |
| 08/12/1997 | US5656478 Smooth muscle tissue formation in vivo using cultured smooth muscle cells combined with an extracellular matrix |
| 08/12/1997 | US5656460 α-glycosyl derivative of the catecholamine or its salt, and its preparation and uses |
| 08/12/1997 | US5656450 Stimulating bone growth by mixing the implant with 1,25-dihydroxy-vitamin d3 |
| 08/12/1997 | US5656288 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
| 08/12/1997 | US5656254 Medical diagnosis |
| 08/12/1997 | US5655521 Facilitating oxygen delivery through lung by administering fluorocarbon liquid having positive equilibrium coefficient of spreading, introducing breathing gas which mixes with and oxygenates fluorocarbon within lung |
| 08/12/1997 | CA1339275C New substituted cephalosporin sulfones as anti-inflammatory and antidegenerative agents |
| 08/07/1997 | WO1997028191A1 Mhc complexes and uses thereof |
| 08/07/1997 | WO1997028184A1 Method of treating beta-amyloid peptide associated conditions using trh |
| 08/07/1997 | WO1997028183A1 Peptide inhibitors of hematopoietic cell proliferation |
| 08/07/1997 | WO1997028178A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | WO1997028163A1 Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
| 08/07/1997 | WO1997028160A1 Endothelin receptor antagonists |
| 08/07/1997 | WO1997028159A1 Endothelin receptor antagonists |
| 08/07/1997 | WO1997028158A1 Endothelin receptor antagonists |
| 08/07/1997 | WO1997028154A1 Endothelin receptor antagonists |